2018-05-01
Colistin versus colistin plus meropenem for severe infections: Authors' reply
Publication
Publication
The Lancet Infectious Diseases , Volume 18 - Issue 5 p. 495- 496
We appreciate Daniele Giacobbe’s Correspondence regarding the importance of colistin minimum inhibitory concentrations.
A study showed that both gradient-based and semi-automated devices can overestimate susceptibility to colistin. [...]
Additional Metadata | |
---|---|
doi.org/10.1016/S1473-3099(18)30223-8, hdl.handle.net/1765/105899 | |
The Lancet Infectious Diseases | |
Organisation | Department of Medical Microbiology and Infectious Diseases |
Paul, M., Carmeli, Y., Daikos, G., Durante-Mangoni, E., Theuretzbacher, U., Mouton, J., & Leibovici, L. (2018). Colistin versus colistin plus meropenem for severe infections: Authors' reply. The Lancet Infectious Diseases, 18(5), 495–496. doi:10.1016/S1473-3099(18)30223-8 |